Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

0.904
Delayed Data
As of Mar 27
 -0.026 / -2.80%
Today’s Change
0.51
Today|||52-Week Range
3.87
+29.16%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues396.0K356.0K735.0K247.0K
 
 
 
 
 
Depreciation And Amortization23.0K23.0K69.0K--
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses5.8M5.9M6.3M6.0M
 
 
 
 
 
Research And Development4.3M4.5M4.9M4.4M
 
 
 
 
 
Total Operating Expenses5.8M5.9M6.4M6.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.4M-5.6M-5.7M-5.8M
 
 
 
 
 
Extraordinary Charge-47.0K-44.0K-4.0K-227.0K
 
 
 
 
 
Other Expenses10.0K-17.0K10.0K101.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.4M-5.6M-5.7M-5.9M
 
 
 
 
 
Income Taxes-569.0K-816.0K-750.0K-1.1M
 
 
 
 
 
Preferred Dividend-50.0K-50.0K-50.0K-50.0K
 
 
 
 
 
Discontinued Operations8.0K7.0K4.0K0.00
 
 
 
 
Net Income-4.9M-4.8M-4.9M-4.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS19.5M22.6M22.7M23.0M
 
 
 
 
 
Shares To Calculate EPS Diluted19.5M22.6M22.7M23.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.25-$0.22-$0.22-$0.21
 
 
 
 
 
EPS Diluted-$0.25-$0.22-$0.22-$0.21
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account